ClinicalTrials.gg
CompletedNCT03828461HDVRUpdated Apr 1, 2024Results posted

Hoarding Disorder Treatment With Virtual Reality

An interventional study of Facilitated group therapy with behavioral practice; 16 weeks in Hoarding Disorder, Hoarding and Clutter, sponsored by Stanford University. Completed at 1 site in United States. Open to participants aged 56 Years and older. Per ClinicalTrials.gov, last updated 2024-04-01.

Sponsored by Stanford University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
13
Allocation
Not applicable
Ages
56 Years and older
Sex
All
01

Study summary

This study explores whether a facilitated peer support group called Buried in Treasures (BIT) and a virtual reality decluttering practice can help individuals with clutter challenges.

Read the detailed description

Individuals with clutter challenges participate in Buried in Treasures Workshop (BIT) that has been shown to improve symptoms of hoarding disorder. The investigators hypothesize that adding virtual reality decluttering practice to the BIT workshop will decrease hoarding symptoms and level of clutter over time.

02

Conditions studied

  • Hoarding Disorder
  • Hoarding
  • Clutter

Keywords

  • hoarding disorder
  • hoarding
  • clutter
03

In context

Hoarding Disorder

32 studies on the registry are indexed under Hoarding Disorder; 5 are open to participants now.

This study's enrollment of 13 is below the median of 37 across 28 interventional studies indexed under Hoarding Disorder.

Browse Hoarding Disorder studies →

Lead sponsor

Stanford University is the lead sponsor of 2,168 studies on the registry; 431 are open to participants now.

Of its 267 completed or terminated interventional studies of FDA-regulated products, 207 (78%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
56 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Age greater than 55
  2. Either gender and all ethno-racial groups
  3. Physically healthy male or non-pregnant female.
  4. Hoarding Disorder primary condition
  5. Willing and able to understand and complete consent and study procedures
  6. English speaking
  7. Participant should have the technology to host Zoom calls

Exclusion criteria

Exclusion Criteria:

  1. Current or past history of bipolar, psychotic or eating disorders, substance dependence, or substance abuse in the last year.
  2. Clinically at risk of suicide with Columbia Suicide Severity Rating Scale (C-SSRS) Suicidal Ideation Subscale of 4 or higher (i.e. suicidal intent without specific plan)
  3. Major medical or neurological conditions that increase the risk of participation or that would prevent completing assigned behavioral practice tasks.
  4. Unable or unwilling to allow study staff into home for home assessment
  5. Currently at high risk for eviction
  6. Animal hoarding or squalor
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
13 participants (actual)

Study arms

  • Experimental
    BITS + VR

    Facilitated group therapy with behavioral practice; 16 weeks

    Behavioral: Facilitated group therapy with behavioral practice; 16 weeks

Interventions

  • BehavioralFacilitated group therapy with behavioral practice; 16 weeks

    Facilitated group therapy for hoarding disorder with behavioral practice

06

What researchers measure

Primary outcomes

  1. Change in Hoarding Symptom Severity as Measured by Saving Inventory-Revised (SI-R)

    The Saving Inventory-Revised scale (SI-R) is a 23-item questionnaire with 3 factor-analytically defined sub-scales for difficulty discarding, excessive clutter, and compulsive acquisition. The total score (sum of 23 items) ranges from 0 to 92. Total score higher than 41 shows significant difficulty with clutter. For the acquisition subscale we sum items 2 (reverse score), 9, 11, 14, 16, 18 and 21. The subscale ranges from 0 to 28 and score greater than 13 indicates difficulty with excessive acquisition. For the difficulty discarding subscale we sum items 4(reverse score), 6, 7, 13, 17, 19, 23. The subscale ranges from 0 to 28 and score greater than 13 indicates difficulty with discarding. For the clutter subscale we sum items 1, 3, 5, 8, 10, 12, 15, 20, 22. The subscale ranges from 0 to 36 and score greater than 15 indicates difficulty with accumulated clutter.

    Time frame: Change from baseline to 16 weeks after treatment

Secondary outcomes

  1. Change in the Severity of Clutter Level as Measured by Clutter Image Rating Scale

    Clutter Imaging Rating (CIR) Scale consists of three sets of photographs of a room, each containing nine photos with varying levels of clutter. This scale assesses the clutter levels in the bedroom, living room and kitchen. Patients were asked to select the picture "that most accurately reflects the amount of clutter in your room". Scores on range from 1 (least cluttered) to 9 (most cluttered). A mean composite score ranging from 1 to 9 was calculated across the three rooms for each individual. A cut-off score of 4 or higher indicate significant clutter.

    Time frame: Change from baseline to 16 weeks after treatment

07

Results

Posted Apr 1, 2024

Participant flow

Participant flow — Overall Study
MilestoneBITS + VR
Started13
Completed9
Not completed4
Withdrew: Lost to follow-up1
Withdrew: Withdrawal by subject3

Outcome measures

PrimaryChange in Hoarding Symptom Severity as Measured by Saving Inventory-Revised (SI-R)

The Saving Inventory-Revised scale (SI-R) is a 23-item questionnaire with 3 factor-analytically defined sub-scales for difficulty discarding, excessive clutter, and compulsive acquisition. The total score (sum of 23 items) ranges from 0 to 92. Total score higher than 41 shows significant difficulty with clutter. For the acquisition subscale we sum items 2 (reverse score), 9, 11, 14, 16, 18 and 21. The subscale ranges from 0 to 28 and score greater than 13 indicates difficulty with excessive acquisition. For the difficulty discarding subscale we sum items 4(reverse score), 6, 7, 13, 17, 19, 23. The subscale ranges from 0 to 28 and score greater than 13 indicates difficulty with discarding. For the clutter subscale we sum items 1, 3, 5, 8, 10, 12, 15, 20, 22. The subscale ranges from 0 to 36 and score greater than 15 indicates difficulty with accumulated clutter.

Time frame:
Change from baseline to 16 weeks after treatment
Reported as:
Mean · score on a scale
Change in Hoarding Symptom Severity as Measured by Saving Inventory-Revised (SI-R)
score on a scaleBITS + VR
Change in Hoarding Symptom Severity as Measured by Saving Inventory-Revised (SI-R)14.2 ± 7.7
SecondaryChange in the Severity of Clutter Level as Measured by Clutter Image Rating Scale

Clutter Imaging Rating (CIR) Scale consists of three sets of photographs of a room, each containing nine photos with varying levels of clutter. This scale assesses the clutter levels in the bedroom, living room and kitchen. Patients were asked to select the picture "that most accurately reflects the amount of clutter in your room". Scores on range from 1 (least cluttered) to 9 (most cluttered). A mean composite score ranging from 1 to 9 was calculated across the three rooms for each individual. A cut-off score of 4 or higher indicate significant clutter.

Time frame:
Change from baseline to 16 weeks after treatment
Reported as:
Mean · score on a scale
Change in the Severity of Clutter Level as Measured by Clutter Image Rating Scale
score on a scaleBITS + VR
Change in the Severity of Clutter Level as Measured by Clutter Image Rating Scale0.77 ± 0.58

Adverse events

Collected over up to 16 weeks. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
BITS + VR0/9 (0%)0/9 (0%)7/9 (77.8%)
Most frequent other events
Showing 10 of 14
Most frequent other events
EventBITS + VR
general discomfortNervous system disorders7/9
eye strainEye disorders5/9
difficulty focusingEye disorders5/9
nauseaGastrointestinal disorders4/9
blurred visionEye disorders4/9
dizzinessNervous system disorders3/9
fatigueNervous system disorders3/9
headacheNervous system disorders3/9
fullness of headNervous system disorders3/9
veritgoNervous system disorders3/9

Baseline characteristics

Age, Continuous
Age, Continuous(years)BITS + VR
Mean64 ± 4.6
Sex: Female, Male
Sex: Female, Male(Participants)BITS + VR
Female5
Male4
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)BITS + VR
Hispanic or Latino0
Not Hispanic or Latino9
Unknown or Not Reported0
Race (NIH/OMB)
Race (NIH/OMB)(Participants)BITS + VR
American Indian or Alaska Native0
Asian1
Native Hawaiian or Other Pacific Islander0
Black or African American0
White8
More than one race0
Unknown or Not Reported0
08

Study locations

1 site
  • Stanford Psychiatry Department
    Stanford, California 94305, United States
09

References and documents

Publications

  • Raila H, Avanesyan T, Valentine KE, Koo B, Huang C, Tsutsumi Y, Andreeff E, Qiu T, Munoz Rodriguez PA, Varias A, Filippou-Frye M, van Roessel P, Bullock K, Periyakoil VS, Rodriguez CI. Augmenting group hoarding disorder treatment with virtual reality discarding: A pilot study in older adults. J Psychiatr Res. 2023 Oct;166:25-31. doi: 10.1016/j.jpsychires.2023.08.002. Epub 2023 Aug 9. PubMed 37716272 ↗

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

10

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jul 2020 to primary completion in Dec 2021, 17 months.

Results were first posted in Apr 2024, 2 years 3 months after primary completion.

Of 20 interventional studies with no phase under Hoarding Disorder, half reached primary completion within 33 months of starting (the median), counting those still running; a quarter within 17 and three quarters within 48. This study's 17 months is below that.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 31, 2019
First posted
Feb 4, 2019
StartActual
Jul 1, 2020
Primary completionActual
Dec 17, 2021
CompletionActual
Dec 17, 2021
Results first posted
Apr 1, 2024
Last update
Apr 1, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 1, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT03828461
Responsible party
Carolyn Rodriguez (Assistant Professor, Stanford University) — Principal investigator
First posted
Feb 4, 2019
Start date
Jul 1, 2020
Primary completion
Dec 17, 2021
Completion
Dec 17, 2021
Results posted
Apr 1, 2024
Last update
Apr 1, 2024

Study contacts

Carolyn I Rodriguez, MD, PhD
principal investigator · Stanford University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion